Student Traditional Chinese Medicine Clinic
Richmond, British Columbia, V6X 3X7, Canada
NCT Number: NCT07637175
This study aims to evaluate the effectiveness and safety of Chinese herbal medicine in improving urinary incontinence symptoms among older adults. Urinary incontinence is a common condition in aging populations that can significantly impact quality of life, yet existing treatments are often limited by side effects or insufficient efficacy.
The primary research question is whether a standardized Chinese herbal formula can reduce the frequency and severity of urinary incontinence compared to a placebo. We hypothesize that participants receiving the herbal intervention will demonstrate greater improvement in urinary symptoms and quality of life measures than those receiving placebo, without significant adverse effects.
To test this hypothesis, a randomized, double-blind, placebo-controlled clinical trial will be conducted. Eligible older adults will be randomly assigned to receive either the herbal treatment or a matched placebo over a defined study period. Outcomes will include validated measures of urinary incontinence severity, frequency of episodes, and patient-reported quality of life.
Potential benefits of this research include generating high-quality evidence on the effectiveness and safety of Chinese herbal medicine for urinary incontinence, which may inform clinical practice and expand treatment options for older adults. If effective, this intervention could offer a complementary or alternative approach with fewer side effects, contributing to improved symptom management and overall well-being in this population.
Trial opening soon.
Get Notified65 year and older
All sexes
Interventional
Not applicable
Richmond, British Columbia, V6X 3X7, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Chinese Herbal Medicine (CHM) supplement
Placebo Control
Time frame: From enrollment to approximately week 4.
Primary outcomes will focus on the frequency and severity of urinary incontinence episodes, measured using validated questionnaires. Min = 0 and Max = 6, with higher scores indicating more frequent/severe urinary incontinence.
Time frame: From enrollment to approximately Week 4.
Secondary outcomes include quality of life, symptom distress, and any adverse events. A mean score for each subscale is calculated (averaging the scores for the items in each subscale) as well as a total score for all 22 items (sum of all subscale scores). The scores are then transformed to a 'Scale score' ranging from 0-100 points for ease of interpretation: Scale score = (sum of the items - lowest possible score)/possible raw score range X 100.
Contact information is provided by the study sponsor or research team.
Kwantlen Polytechnic University
Other
Effectiveness of Chinese Herbal Medicine for Older Adults With Urinary Incontinence: A Randomized Double-Blind Placebo-Controlled Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07124390
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
London, United Kingdom
View Trial DetailsNCT07628036
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Barcelona, Spain
View Trial DetailsNCT07045415
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Konya, Turkey (Türkiye)
View Trial DetailsNCT07599189
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Oran, Oran Province, Algeria
View Trial Details